Combined Oxidative Phosphorylation Deficiency Caused by Mutation in AARS2

Combined oxidative phosphorylation deficiency caused by mutation in AARS2 is a very rare inherited disease that mainly damages the tiny “power stations” inside cells, called mitochondria. These mitochondria normally make energy for the body using a process called oxidative phosphorylation. In this disease, that process does not work well, so the cells cannot make enough energy. []

Combined oxidative phosphorylation deficiency caused by mutation in the AARS2 gene is a very rare and serious mitochondrial disease. It is also called combined oxidative phosphorylation deficiency 8 (COXPD8). In this disease, the tiny “power stations” inside cells (mitochondria) cannot make enough energy (ATP) because several parts of the respiratory chain are not working properly. This happens because the AARS2 gene, which helps build a key protein for mitochondrial protein-making, is changed (mutated). Children often develop severe heart muscle thickening (hypertrophic cardiomyopathy), weak muscles, breathing problems, and sometimes brain and development problems. Sadly, the illness can be life-threatening, especially in infancy.

The main known form is called combined oxidative phosphorylation deficiency type 8 (COXPD8). It happens when both copies of the AARS2 gene in a child are changed (mutated). This gene normally makes an enzyme called mitochondrial alanyl-tRNA synthetase 2. This enzyme helps mitochondria build many of their own proteins. When the enzyme does not work well, several energy-making complexes in the mitochondria fail together, so the heart, brain, muscles, and sometimes lungs and other organs can become very sick. []

Most babies with the classic form get very sick in early life with severe heart muscle disease (hypertrophic cardiomyopathy), weak muscles, and breathing problems. Many cases are sadly fatal in infancy. Some people with AARS2 changes can also develop brain white-matter disease (leukoencephalopathy) and, in females, early ovarian failure, usually later in life. These are different but related forms of AARS2-related disease. []

Other names

Doctors and databases use several other names for this condition. These include:

• Combined oxidative phosphorylation deficiency 8 (COXPD8)

• Combined oxidative phosphorylation defect type 8

• Combined oxidative phosphorylation deficiency caused by mutation in AARS2

• Cardiomyopathy, hypertrophic, mitochondrial, fatal infantile (AARS2-related)

• AARS2-related disorder / AARS2-related mitochondrial cardiomyopathy

All these names point to the same basic problem: a mitochondrial energy-making defect caused by changes in the AARS2 gene. []

What goes wrong in the body

The AARS2 gene gives the instructions to make the mitochondrial enzyme alanyl-tRNA synthetase 2. This enzyme’s job is to attach the amino acid alanine to a special helper molecule called tRNA-Ala. This step is essential for building many mitochondrial proteins that are part of the respiratory chain complexes (complexes I, III, IV and V) used in oxidative phosphorylation. []

When both copies of AARS2 are mutated, the enzyme can be weak or unstable. It may attach alanine poorly or make more mistakes. This leads to bad or missing mitochondrial proteins. As a result, the cell cannot assemble normal respiratory chain complexes, and the mitochondria cannot make enough ATP (energy). []

Organs that need a lot of energy, such as the heart, brain, skeletal muscles, and lungs, are affected the most. In infants, the heart is often the first organ to fail. In some older patients, the brain’s white matter is mainly affected, leading to walking problems, movement disorders, and thinking or behavior changes. []

Types

Doctors now think of AARS2-related disease as a spectrum with several forms:

• Infantile-onset hypertrophic cardiomyopathy form (classic COXPD8)

  • Severe heart muscle thickening in babies

  • Low muscle tone and breathing failure

  • Often fatal in early life. []

• Prenatal or very early neonatal lethal form

  • Problems may already start in the womb

  • Can include fluid build-up (hydrops), very under-developed lungs, and severe heart failure in newborns. []

• Childhood-onset encephalomyopathy / mixed form

  • Some children may have muscle weakness and developmental problems with or without clear heart disease

  • There may be seizures or brain white-matter changes. []

• Adult-onset leukoencephalopathy with or without ovarian failure

  • In some adults, especially women, the main problem is progressive white-matter disease of the brain, movement disorders, and sometimes early ovarian failure (stopping periods young). []

All these types come from changes in the same gene, AARS2, but different exact mutations and other genetic or environmental factors change how and when the disease shows itself. []

Causes

All direct causes are linked to AARS2 gene changes and the way they damage mitochondrial energy making.

1. Autosomal recessive AARS2 mutation
   The main cause is being born with harmful changes in both copies of the AARS2 gene, one from each parent. This “autosomal recessive” pattern means parents are usually healthy carriers but can have an affected child if both pass on the changed gene. []

2. Carrier parents of AARS2 variants
   When both parents silently carry one faulty AARS2 copy, each pregnancy has a 25% chance of producing a child with combined oxidative phosphorylation deficiency. This family situation is a strong genetic cause. []

3. Missense mutations in AARS2
   Many reported disease-causing variants are “missense” changes. One amino acid in the enzyme is swapped for another. This can distort the enzyme shape, slow its work, or make it more likely to break down, so mitochondrial protein building becomes weak. []

4. Nonsense or truncating mutations
   Some mutations create an early “stop” signal. The enzyme is cut short and often destroyed by the cell. Without enough full-length AARS2 protein, the mitochondria lose a key step in protein synthesis and energy production. []

5. Splice-site mutations
   Mutations in the parts of the gene that control splicing can lead to missing or extra pieces of the AARS2 mRNA. This may produce a faulty enzyme with missing regions or cause the message to be destroyed, again lowering enzyme levels. []

6. Deletions or duplications in AARS2
   Larger changes, where part of the gene is deleted or copied twice, can also disrupt the enzyme. These structural changes are less common but can still cause COXPD8. []

7. Consanguinity (parents related by blood)
   In some reported families, the parents are related (for example, cousins). This increases the chance that both carry the same rare AARS2 mutation and pass it on to the child. []

8. Founder mutations in certain groups
   A specific harmful variant can appear more often in a small population or region because of a “founder” effect. Families from that group can have repeated cases of AARS2-related disease. []

9. Loss of aminoacylation activity
   The main job of AARS2 is to add alanine to its tRNA. Many disease variants reduce this core activity. Without enough correctly “charged” tRNA-Ala, mitochondria cannot build key respiratory proteins properly. []

10. Loss of proofreading (editing) function
    AARS2 also checks for mistakes and clears wrongly attached amino acids. Some mutations may harm this proofreading role. This can cause more faulty mitochondrial proteins, which then fail to work in the respiratory chain. []

11. Defective mitochondrial protein synthesis overall
    When AARS2 does not work, many mitochondrial proteins are under-made or mis-made. This widespread protein problem is a direct cause of combined oxidative phosphorylation deficiency, because the respiratory complexes need many correctly built subunits. []

12. Failure of respiratory complexes I and IV assembly
    Studies on heart tissue from affected babies show that complexes I and IV, and the larger “super-complexes” they form, are poorly assembled. This weak assembly is a mechanical cause of poor oxidative phosphorylation and heart failure. []

13. Reduced ATP supply to heart muscle
    The heart needs constant high energy. When mitochondrial ATP production drops, the heart muscle cells cannot contract properly. Over time this causes thickened, weak heart muscle (hypertrophic cardiomyopathy) and heart failure in infants. []

14. Energy failure in developing brain
    The brain’s white matter and deep structures also demand high energy. AARS2 defects can lead to loss of myelin and leukoencephalopathy, causing movement problems, cognitive decline, and psychiatric symptoms, especially in adult forms. []

15. Secondary oxidative stress
    When the respiratory chain is damaged, electrons can leak and form reactive oxygen species. These “free radicals” can further injure mitochondrial membranes and proteins, deepening the energy crisis in cells. []

16. Apoptosis (programmed cell death) of heart and brain cells
    Prolonged mitochondrial failure can trigger programmed cell death pathways. This loss of cells in heart, brain, and muscle can worsen cardiomyopathy and neurodegeneration. []

17. Possible modifying mitochondrial DNA variants
    Many mitochondrial proteins are made from mitochondrial DNA. Differences or variants in mitochondrial DNA may change how strongly an AARS2 mutation shows, even in the same family. This can partly “cause” milder or more severe disease. []

18. Other nuclear gene modifiers
    Some patients may have additional variants in other mitochondrial genes that slightly worsen or soften the effect of AARS2 mutations. These gene–gene interactions are not fully known but can influence disease expression. []

19. Developmental vulnerability of fetus and newborn
    The fetus and newborn are especially sensitive to energy shortages. AARS2 defects during this period can lead to lung under-development, hydrops, and early cardiac failure, contributing directly to the severe infantile form. []

20. Unknown or not yet identified factors
    Even with the same AARS2 mutations, some people have mainly heart disease, while others have brain and ovarian problems. This shows that unknown genetic or environmental factors also contribute to how the disease appears. []

Symptoms

Symptoms can vary with age and disease type, but these are common features reported in AARS2-related combined oxidative phosphorylation deficiency.

1. Poor feeding in newborns
   Many affected babies have trouble sucking, swallowing, or staying awake long enough to feed. This happens because they are weak and easily tired due to low energy in muscles and heart. []

2. Failure to gain weight (failure to thrive)
   Because feeding is difficult and energy use is high, infants may gain weight very slowly or even lose weight. This long-term poor weight gain is a key warning sign. []

3. Low muscle tone (floppy baby)
   Babies often feel “floppy” when held. Doctors call this hypotonia. The muscles do not have normal tension because the cells do not have enough energy to contract well. []

4. Muscle weakness
   As children grow, they may be slow to lift their head, sit, stand, or walk. In older patients, weakness of arms and legs can limit daily activities and make falls more likely. []

5. Breathing problems
   The heart and respiratory muscles work together. When they are weak, babies can breathe fast, have chest retractions, or need oxygen. Some may develop respiratory failure and need ventilator support. []

6. Enlarged heart (cardiomegaly) and thick heart muscle
   Imaging and exam often show a big, thick heart, especially the left ventricle. This is hypertrophic cardiomyopathy, a central feature of the infantile COXPD8 form. []

7. Heart failure signs
   Babies or children may have poor pulses, cold hands and feet, swelling of legs or belly, and trouble feeding or breathing when lying flat. These signs show that the heart cannot pump enough blood. []

8. Extreme tiredness and low energy
   Even without obvious heart failure, many patients feel very tired with small efforts. Children may not keep up with peers, and adults may have severe fatigue and exercise intolerance. []

9. Developmental delay
   Because of brain and muscle involvement, milestones such as sitting, walking, and talking may come late. In some forms, thinking and learning skills are also affected. []

10. Seizures
    Some children have seizures due to brain involvement and metabolic stress. These can be focal or generalized and may need anti-seizure medicines. []

11. Movement problems and ataxia
    In adult AARS2-related leukoencephalopathy, many patients develop unsteady walking (ataxia), stiffness or spasticity, tremor, or Parkinson-like features. These result from damage to brain pathways that control movement. []

12. Cognitive decline and behavior changes
    Some adults slowly lose memory, thinking speed, and problem-solving skills. Personality and mood can also change, with depression, anxiety, or other psychiatric symptoms. []

13. Headaches or other neurologic complaints
    Patients with brain involvement may complain of headaches, vision problems, or sensory changes. These often go together with MRI signs of white-matter disease. []

14. Premature ovarian failure in females
    Many women with AARS2-related leukoencephalopathy develop early ovarian failure. They may have irregular periods, stop menstruating early, or have trouble getting pregnant. This combination of white-matter disease and ovarian failure is known as “ovarioleukodystrophy.” []

15. Early death in severe infantile cases
    In the classic infantile COXPD8 form, severe heart and lung problems can lead to death in the first months or years of life, even with strong intensive care. This reflects how profound the energy failure is in vital organs. []

Diagnostic tests

Doctors use many tests together to diagnose combined oxidative phosphorylation deficiency caused by AARS2 mutations. No single test is enough.

Physical exam tests

1. Full general physical examination
   The doctor checks weight, height, head size, body proportions, skin color, swelling, and any unusual facial or body features. In this disease, they may see poor growth, enlarged liver, or fluid build-up, which suggest heart or metabolic problems. []

2. Cardiovascular examination
   Using a stethoscope, the doctor listens for extra heart sounds, murmurs, or gallops and checks pulses and blood pressure. Signs like fast heart rate, weak pulses, and enlarged heart on percussion or imaging point toward hypertrophic cardiomyopathy. []

3. Neurological examination
   The doctor tests muscle tone, strength, reflexes, coordination, and cranial nerve function. In AARS2-related disease, they may find low tone in infants or spasticity, ataxia, and abnormal reflexes in older patients, showing brain and muscle involvement. []

4. Respiratory examination
   Breathing rate, chest movement, oxygen saturation, and signs of respiratory distress are checked. Fast breathing, chest retractions, or low oxygen levels can signal heart failure or weak respiratory muscles from mitochondrial disease. []

Manual (bedside) functional tests

5. Manual muscle strength testing
   In older infants and children, doctors push against arms and legs while the child resists. Reduced resistance and easy fatigue show muscle weakness, which is common in mitochondrial disorders including AARS2-related disease. []

6. Developmental screening tasks
   Simple tasks (reaching for a toy, sitting, standing, walking, drawing) are used to see if milestones are appropriate for age. Delayed skills support the suspicion of an early-onset neurologic or metabolic condition. []

7. Gait and coordination assessment
   In older patients, the doctor watches walking, turning, heel-to-toe walking, and finger-to-nose tests. Unsteady gait, wide-based stance, and poor coordination suggest ataxia from cerebellar or white-matter involvement in AARS2 disease. []

8. Simple exercise tolerance tests
   Short walk or step tests can show how quickly a patient becomes breathless or exhausted. Very low exercise tolerance is a common bedside clue of mitochondrial cardiomyopathy or myopathy. []

Lab and pathological tests

9. Blood lactate and pyruvate levels
   In many mitochondrial diseases, blood lactate is raised because cells shift to less efficient energy pathways. High lactate and sometimes an abnormal lactate-to-pyruvate ratio can support a mitochondrial disorder like COXPD8, though they are not fully specific. []

10. Arterial or capillary blood gas analysis
    This test measures pH and bicarbonate. In severe mitochondrial failure, metabolic acidosis (low pH, low bicarbonate) can appear, especially during crises. It helps doctors judge how sick the child is and guide urgent care. []

11. Serum creatine kinase (CK) and liver enzymes
    CK shows muscle damage, and transaminases show liver stress. These may be mildly or moderately raised, indicating muscle and liver involvement in the mitochondrial disorder, although normal results do not exclude the disease. []

12. Acylcarnitine profile and urine organic acids
    These metabolic screening tests help rule out other inherited metabolic diseases that can mimic mitochondrial cardiomyopathy. In AARS2-related COXPD8 they may be normal or show nonspecific changes, but they are still an important part of the work-up. []

13. Genetic testing for AARS2
    Next-generation sequencing panels or exome sequencing can identify biallelic pathogenic variants in AARS2. Finding two disease-causing variants that fit the clinical picture confirms the diagnosis and can allow carrier testing in the family. []

14. Muscle biopsy with histology and respiratory chain enzyme assays
    A small muscle sample can be examined under the microscope and tested for the activity of complexes I–IV. In COXPD8, reduced activity of multiple complexes and structural mitochondrial changes support the diagnosis of combined oxidative phosphorylation deficiency. []

Electrodiagnostic tests

15. Electrocardiogram (ECG)
    An ECG records the heart’s electrical activity. In AARS2-related cardiomyopathy, ECG may show thickened heart muscle signs, conduction delays, or arrhythmias. It is a basic tool to assess how the heart is coping. []

16. Electroencephalogram (EEG)
    EEG measures the brain’s electrical activity with scalp electrodes. In patients with seizures or episodic confusion, EEG can show abnormal patterns, helping to diagnose seizure type and monitor brain involvement in AARS2-related disease. []

17. Electromyography (EMG) and nerve conduction studies
    These tests use tiny needles and surface electrodes to study muscle and nerve function. They can show whether weakness comes mainly from muscle (myopathy) or nerve damage (neuropathy), which helps characterize the neuromuscular part of the mitochondrial disorder. []

Imaging tests

18. Echocardiography (heart ultrasound)
    Echocardiography uses sound waves to create moving pictures of the heart. In COXPD8 it often shows thick walls, small cavity size, and reduced pumping function, confirming hypertrophic cardiomyopathy and guiding treatment decisions. []

19. Brain MRI
    MRI scans can show white-matter changes, atrophy, or other patterns of leukoencephalopathy in patients with neurologic forms of AARS2-related disease. The pattern of white-matter damage, together with ovarian failure in women, strongly points toward AARS2 mutations. []

20. Chest X-ray or thoracic imaging
    Chest X-ray can show an enlarged heart and signs of lung congestion from heart failure. In some very severe fetal and neonatal cases, imaging and autopsy studies also show under-developed lungs (pulmonary hypoplasia). These findings support the diagnosis of severe mitochondrial cardiomyopathy such as AARS2-related COXPD8. []

Non-Pharmacological Treatments (Therapies and Other Measures)

Below, each item includes a short description, plus clear Purpose and Mechanism in simple words.

1. Regular care by a mitochondrial specialist team
   A child with AARS2-related combined oxidative phosphorylation deficiency should be followed in a center that understands mitochondrial diseases. The team usually includes a metabolic specialist, cardiologist, neurologist, dietitian, physiotherapist, and palliative care staff.
   Purpose: To coordinate all care and catch problems early.
   Mechanism: Regular check-ups, tests, and team meetings help adjust treatments quickly when heart, brain, or feeding problems change.

2. Careful nutrition planning with a dietitian
   Many children cannot eat enough or safely by mouth. A dietitian calculates calories, protein, fat, vitamins, and fluid needs in a very detailed way. Sometimes high-energy feeds or tube feeding are needed.
   Purpose: To prevent under-nutrition and low blood sugar, which can make mitochondrial stress worse.
   Mechanism: Frequent small meals or continuous feeds give a steady energy supply so cells do not have to overwork damaged mitochondria.

3. Avoiding fasting and dehydration
   Long gaps without food, vomiting, or diarrhea can be dangerous in mitochondrial disease. Families are taught “sick-day rules” to give extra fluids and carbohydrates early.
   Purpose: To reduce the risk of metabolic decompensation, lactic acidosis, and shock.
   Mechanism: Extra sugar and fluids provide easy fuel for cells and help keep blood volume and circulation stable, so the body does not need to break down muscle for energy.

4. Physiotherapy (physical therapy)
   A physiotherapist designs gentle exercises, stretching, and sometimes breathing exercises. Sessions are adapted to the child’s energy limits.
   Purpose: To keep joints flexible, maintain as much strength as possible, and prevent contractures.
   Mechanism: Low-intensity, regular motion stimulates muscles and circulation without over-stressing damaged mitochondria, and helps prevent “disuse” weakness.

5. Occupational therapy
   Occupational therapists work on daily living skills like sitting, holding objects, feeding, and playing. They may suggest special chairs, splints, or adapted toys.
   Purpose: To improve independence and safety in everyday tasks.
   Mechanism: Training small step-by-step skills and using adaptive devices reduces effort and energy cost for the child, while still supporting development.

6. Speech and feeding therapy
   Some children have weak mouth muscles, swallowing difficulties, or developmental delay. Speech-language therapists teach safe swallowing, better feeding positions, and early communication methods.
   Purpose: To reduce choking and aspiration and support language development.
   Mechanism: Targeted exercises strengthen muscles used for swallowing and speech, and strategies like thickened feeds or special nipples lower aspiration risk.

7. Respiratory therapy and airway clearance
   When muscles are weak, clearing mucus can be hard. Respiratory therapists can teach cough-assist, chest physiotherapy, and use of devices like suction or non-invasive ventilation.
   Purpose: To prevent pneumonia and support breathing during infections or sleep.
   Mechanism: Mechanical support and techniques help move mucus out of the lungs and reduce the work of breathing, which lowers oxygen demand and energy stress.

8. Cardiac rehabilitation and activity pacing
   The cardiologist and physiotherapist set limits for safe physical activity. Over-exertion can trigger heart failure or arrhythmias.
   Purpose: To keep the heart stable while still allowing gentle activity.
   Mechanism: Planned short activities with rest periods reduce sudden spikes in heart work, helping the weakened heart muscle cope better.

9. Vaccinations and infection prevention
   Preventing infections is very important. Routine vaccines (as advised by the child’s doctors) and good hand hygiene lower the risk of pneumonia and sepsis.
   Purpose: To avoid stressful illnesses that can trigger decompensation and hospital stays.
   Mechanism: Vaccines train the immune system to fight specific germs more quickly and safely, reducing the “energy cost” of fighting infections.

10. Written emergency plan
    Families receive a written letter for emergency rooms, explaining the disease, unsafe medicines, and emergency fluids.
    Purpose: To speed correct treatment during crises.
    Mechanism: Ready instructions help emergency doctors give glucose and fluids early, avoid harmful drugs, and call the metabolic team quickly.

11. Avoidance of mitochondrial-toxic medicines
    Some medicines (for example, certain anesthetics, valproic acid, aminoglycosides) can worsen mitochondrial function. Doctors usually avoid or use them only if absolutely needed.
    Purpose: To prevent extra injury to already fragile mitochondria.
    Mechanism: By choosing safer alternatives, the risk of sudden liver failure, lactic acidosis, or worsening weakness is reduced.

12. Careful anesthesia and surgery planning
    If surgery is needed, anesthesiologists experienced with mitochondrial disease prepare special plans (choice of drugs, temperature control, glucose infusion).
    Purpose: To lower the risk of complications during and after operations.
    Mechanism: Close control of temperature, oxygen, blood sugar, and blood pressure reduces sudden energy demands on damaged mitochondria.

13. Assistive devices and mobility aids
    Wheelchairs, walkers, standing frames, and supportive seating can be very helpful.
    Purpose: To maintain mobility and safe positioning with less fatigue.
    Mechanism: Devices carry part of the body weight, so muscles and heart use less energy while the child can still move, play, and interact.

14. Sleep and positioning management
    Good sleep hygiene, proper pillows, and sometimes specialized mattresses can improve comfort and breathing at night.
    Purpose: To reduce night-time breathing problems and improve daytime energy.
    Mechanism: Proper positioning keeps the airway more open and lowers the effort needed to breathe, especially in children with weak muscles or enlarged hearts.

15. Psychological and social support for family
    Chronic, severe illness affects the whole family. Counseling, support groups, and social worker help are important.
    Purpose: To reduce anxiety, depression, and caregiver burnout.
    Mechanism: Emotional support, coping skills, and practical help improve family resilience, which indirectly improves the child’s day-to-day care.

16. Early developmental intervention and special education
    Many children need early stimulation programs and tailored school plans.
    Purpose: To maximize developmental potential despite medical challenges.
    Mechanism: Structured play, learning activities, and special classroom supports help the brain use its remaining capacity more efficiently.

17. Palliative care involvement
    Palliative care does not mean “giving up.” It focuses on comfort, symptom control, and family wishes from early in the disease.
    Purpose: To improve quality of life and guide complex decisions.
    Mechanism: Palliative teams manage pain, breathlessness, and distress, and help families plan for emergencies and future choices.

18. Genetic counseling for parents and relatives
    Because AARS2-related disease is usually autosomal recessive, each pregnancy has a recurrence risk. Genetic counseling explains this clearly.
    Purpose: To support informed decisions about future pregnancies and testing.
    Mechanism: Carrier testing and, when appropriate, prenatal or pre-implantation diagnosis help families plan in line with their values.

19. Home monitoring and telemedicine
    Families may be taught to monitor weight, breathing, oxygen saturation, and signs of heart failure at home.
    Purpose: To detect early changes and contact doctors quickly.
    Mechanism: Small changes are noticed sooner, so treatments can be adjusted before the child becomes very sick.

20. Care coordination across hospitals
    Because this is rare, local hospitals may have little experience. Sharing records, letters, and emergency plans between centers is vital.
    Purpose: To ensure consistent, safe care in every hospital visit.
    Mechanism: Good communication avoids repeated tests, wrong medicines, and delays in treatment.

---

Drug Treatments

There is no drug that cures the AARS2 mutation itself. Medicines target complications like seizures, cardiomyopathy, or heart failure. Many of the medicines listed below are FDA-approved for general conditions such as seizures or heart failure, and their official prescribing information is available on accessdata.fda.gov (for example, for levetiracetam, carvedilol, enalapril, furosemide, and levocarnitine).

For each drug: description, Class, Dosage (general), Timing, Purpose, Mechanism, Side effects are described in simple language. Exact doses must always be set by the treating doctor.

1. Levetiracetam (Keppra and similar)
   An antiepileptic medicine often chosen first in mitochondrial disease because it usually has less mitochondrial toxicity.

   • Class: Antiepileptic drug (AED).

   • Dosage: Usually given twice a day; dose depends on weight and kidney function.

   • Time: Long-term, daily.

   • Purpose: To prevent or reduce seizures.

   • Mechanism: Calms over-active nerve cells by affecting neurotransmitter release.

   • Side effects: Sleepiness, mood changes, irritability; rarely low blood counts or allergic reactions.

2. Benzodiazepines (e.g., lorazepam, diazepam, midazolam)
   These drugs are used for emergency seizure control and sometimes for short-term severe agitation.

   • Class: Benzodiazepine sedatives.

   • Dosage: Given by mouth, IV, or nose/cheek in carefully calculated doses.

   • Time: Short-term, for acute seizures or crisis.

   • Purpose: To stop seizures quickly.

   • Mechanism: Enhance GABA, a calming brain messenger.

   • Side effects: Sleepiness, breathing suppression, low blood pressure if given fast or in high dose.

3. Lamotrigine
   Another modern antiepileptic that may be used if seizures are not controlled by levetiracetam.

   • Class: Sodium-channel-blocking AED.

   • Dosage: Started very slowly and increased step by step to avoid rash.

   • Time: Long-term, daily.

   • Purpose: To control focal or generalized seizures.

   • Mechanism: Stabilizes nerve cell membranes to prevent sudden firing.

   • Side effects: Skin rash (rarely severe), dizziness, nausea.

4. Carvedilol (Coreg)
   This medicine treats heart failure and certain cardiomyopathies by blocking stress hormones on the heart.

   • Class: Beta-blocker with alpha-blocking activity.

   • Dosage: Started at a very low dose twice daily and slowly increased while monitoring blood pressure and heart rate.

   • Time: Long-term in chronic heart failure.

   • Purpose: To improve heart function and symptoms of heart failure.

   • Mechanism: Reduces heart rate and workload, allowing the weakened heart to pump more efficiently over time.

   • Side effects: Low blood pressure, slow pulse, dizziness, tiredness.

5. Enalapril (Vasotec)
   ACE inhibitors like enalapril help relax blood vessels and reduce heart strain.

   • Class: Angiotensin-converting enzyme (ACE) inhibitor.

   • Dosage: Low starting dose once or twice daily, adjusted slowly.

   • Time: Long-term in heart failure.

   • Purpose: To lower pressure and improve pumping in a thickened heart.

   • Mechanism: Blocks formation of angiotensin II, a hormone that tightens blood vessels.

   • Side effects: Cough, low blood pressure, kidney function changes, high potassium, rare angioedema.

6. Furosemide
   A “water tablet” used for fluid overload, lung congestion, or edema in heart failure.

   • Class: Loop diuretic.

   • Dosage: Carefully calculated dose by mouth or injection, adjusted based on weight and urine output.

   • Time: Regular or intermittent, depending on swelling and breathing.

   • Purpose: To remove extra fluid so the child can breathe better and the heart can pump more easily.

   • Mechanism: Makes the kidneys pass more salt and water into urine.

   • Side effects: Dehydration, low blood pressure, low potassium, hearing problems if given too fast IV.

7. Spironolactone
   This medicine helps heart failure and reduces potassium loss from other diuretics.

   • Class: Aldosterone antagonist (potassium-sparing diuretic).

   • Dosage: Once or twice daily, dose based on weight and kidney function.

   • Time: Long-term in many heart failure regimens.

   • Purpose: To improve heart remodeling and control fluid.

   • Mechanism: Blocks aldosterone, a hormone that holds salt and water.

   • Side effects: High potassium, breast enlargement, stomach upset.

8. Levocarnitine (Carnitor)
   Levocarnitine helps move fatty acids into mitochondria. It is often used in mitochondrial disease, especially if blood carnitine is low.

   • Class: Metabolic agent / amino-acid derivative.

   • Dosage: Oral or IV, divided several times per day according to weight and lab results.

   • Time: Long-term in many patients.

   • Purpose: To support energy production and reduce toxic fatty acid build-up.

   • Mechanism: Carries long-chain fatty acids into mitochondria for oxidation and energy generation.

   • Side effects: Diarrhea, fishy body odor at high doses.

9. Bicarbonate or citrate solutions
   These alkaline medicines are used when lactic acidosis or metabolic acidosis is severe.

   • Class: Systemic alkalinizing agents.

   • Dosage: Tailored based on blood gas results, usually IV during crises.

   • Time: Short-term in acute illness.

   • Purpose: To correct dangerous acid levels in the blood.

   • Mechanism: Neutralizes excess acid, helping organs function better.

   • Side effects: Fluid overload, electrolyte shifts, risk of alkalosis if overcorrected.

10. Antibiotics (e.g., ceftriaxone)
    Rapid treatment of serious infections is vital in this disease.

    • Class: Antibiotic (cephalosporin in the example).

    • Dosage: IV or IM based on weight and infection site.

    • Time: Short-term course as directed.

    • Purpose: To clear bacterial infections quickly and prevent sepsis.

    • Mechanism: Blocks bacterial cell wall building, killing the germ.

    • Side effects: Allergic reactions, diarrhea, changes in gut bacteria.

11. Proton pump inhibitors (e.g., omeprazole)
    Used when reflux, stomach ulcers, or steroid use make stomach protection important.

    • Class: Proton pump inhibitor (PPI).

    • Dosage: Once or twice daily.

    • Time: Short- or long-term depending on need.

    • Purpose: To reduce acid and protect the stomach and esophagus.

    • Mechanism: Blocks the acid pump in stomach cells.

    • Side effects: Headache, diarrhea, with long use possible low magnesium or vitamin B12.

12. Antiemetics (e.g., ondansetron)
    Vomiting can quickly lead to dehydration and acidosis.

    • Class: 5-HT3 receptor antagonist.

    • Dosage: Oral or IV dose adjusted by weight.

    • Time: Short-term around illness or surgery.

    • Purpose: To control nausea and vomiting.

    • Mechanism: Blocks serotonin receptors in gut and brain that trigger vomiting.

    • Side effects: Constipation, headache, rare heart rhythm changes.

13. Short-acting bronchodilators (e.g., salbutamol / albuterol)
    If wheeze or asthma-like symptoms occur, this inhaled drug may be used.

    • Class: Beta-2 agonist.

    • Dosage: Inhaled puffs or nebulizer, as prescribed.

    • Time: As-needed.

    • Purpose: To open airways and ease breathing.

    • Mechanism: Relaxes smooth muscle in airway walls.

    • Side effects: Tremor, fast heart rate, nervousness.

14. Low-dose opioids for severe pain or breathlessness (carefully used)
    In advanced disease, low doses may ease suffering.

    • Class: Opioid analgesic.

    • Dosage: Very small doses, carefully titrated.

    • Time: As needed for severe symptoms.

    • Purpose: To relieve pain or distressing breathlessness.

    • Mechanism: Binds opioid receptors in brain and spinal cord to reduce pain signals.

    • Side effects: Constipation, sleepiness, suppressed breathing if over-dosed.

15. Digoxin (selected cases)
    Sometimes used for heart failure or certain rhythm problems, though carefully in infants.

    • Class: Cardiac glycoside.

    • Dosage: Very small weight-based doses with blood level monitoring.

    • Time: Long-term if indicated.

    • Purpose: To improve heart pumping and control rate in some arrhythmias.

    • Mechanism: Increases the strength of heart contractions and slows conduction through the AV node.

    • Side effects: Nausea, arrhythmias if levels are too high.

16. Low-dose aspirin (in selected cardiac situations)
    In some children with high clot risk, doctors may advise low-dose aspirin.

    • Class: Antiplatelet / NSAID.

    • Dosage: Once daily low dose only if clearly indicated.

    • Time: Long-term in high-risk cases.

    • Purpose: To reduce risk of clot formation.

    • Mechanism: Irreversibly blocks platelet COX-1, lowering thromboxane A2 and platelet clumping.

    • Side effects: Bleeding, stomach irritation.

17. Steroids (short courses only when clearly needed)
    Given, for example, for severe lung inflammation.

    • Class: Glucocorticoids.

    • Dosage: Short course, dose and taper chosen by specialist.

    • Time: Short-term.

    • Purpose: To reduce life-threatening inflammation.

    • Mechanism: Suppress immune and inflammatory pathways.

    • Side effects: High blood sugar, infection risk, muscle weakness with long use.

18. IV immunoglobulin (IVIG) in selected immune complications
    Rarely, if immune problems or specific infections occur, IVIG may be used.

    • Class: Pooled human antibodies.

    • Dosage: IV infusion based on weight.

    • Time: Single or repeated courses.

    • Purpose: To temporarily support the immune system or treat immune-mediated disease.

    • Mechanism: Provides ready-made antibodies and modulates immune activity.

    • Side effects: Headache, fever, rare kidney issues or clots.

19. Sedation medicines for procedures (carefully chosen)
    Drugs like short-acting anesthetics or sedatives are used with special caution.

    • Class: Various (e.g., propofol, midazolam).

    • Dosage: Lowest effective dose given by experienced anesthetist.

    • Time: During procedures only.

    • Purpose: To keep the child comfortable and still during tests or minor surgery.

    • Mechanism: Depress brain activity so the child does not feel pain or remember the procedure.

    • Side effects: Low blood pressure, breathing suppression, mitochondrial stress if not carefully managed.

20. Other individualized heart medicines
    Depending on heart rhythm and function, additional drugs like other ACE inhibitors, angiotensin receptor blockers, or antiarrhythmics may be used.

    • Class: Various cardiovascular agents.

    • Dosage/Time: Highly individualized.

    • Purpose: To fine-tune blood pressure, heart rhythm, and heart output.

    • Mechanism: Each acts on different hormonal or electrical pathways in the heart and vessels.

    • Side effects: Vary widely, so close monitoring is needed.

---

Dietary Molecular Supplements

Evidence for supplements in mitochondrial disease is mixed, but many centers use a “mitochondrial cocktail” based on expert opinion and small studies.

For each: description, Dosage (general), Function, Mechanism.

1. Coenzyme Q10 (ubiquinone or ubiquinol)
   CoQ10 is a vitamin-like substance naturally found in mitochondria and helps move electrons in the respiratory chain.

   • Dosage: Often given two or three times daily; dose is weight-based and chosen by the specialist.

   • Function: To support ATP production and possibly reduce fatigue.

   • Mechanism: Works as an electron carrier between complexes I/II and III and as an antioxidant that may protect membranes from free-radical damage.

2. Riboflavin (vitamin B2)
   Riboflavin is a water-soluble vitamin needed for enzymes in complexes I and II.

   • Dosage: Daily oral dose; sometimes higher than usual vitamin doses in mitochondrial disease.

   • Function: To support enzyme activity in the electron transport chain.

   • Mechanism: Converted into FAD and FMN, which are co-factors for many mitochondrial redox enzymes.

3. Thiamine (vitamin B1)
   Thiamine helps break down carbohydrates safely.

   • Dosage: Daily oral or sometimes IV doses decided by the doctor.

   • Function: To support pyruvate dehydrogenase and related enzymes, which link glycolysis to the Krebs cycle.

   • Mechanism: Acts as a co-factor, helping convert pyruvate into acetyl-CoA, reducing lactate build-up.

4. Alpha-lipoic acid
   An antioxidant and co-factor in mitochondrial metabolism.

   • Dosage: Oral doses in divided amounts; not used in all children.

   • Function: To reduce oxidative stress and support energy metabolism.

   • Mechanism: Participates in dehydrogenase complexes and can neutralize reactive oxygen species.

5. L-arginine and L-citrulline
   Amino acids used mainly in other mitochondrial disorders with stroke-like episodes, but sometimes considered for vascular support.

   • Dosage: Carefully adjusted oral or IV doses, especially in acute illness.

   • Function: To support nitric oxide production and blood vessel function.

   • Mechanism: Serve as precursors for nitric oxide, which regulates vessel tone and blood flow.

6. Vitamin C (ascorbic acid)
   A common antioxidant vitamin.

   • Dosage: Daily oral dose not exceeding safe limits for age.

   • Function: To help control oxidative stress and support collagen and immune function.

   • Mechanism: Donates electrons to neutralize free radicals and helps recycle other antioxidants like vitamin E.

7. Vitamin E (tocopherols)
   Fat-soluble antioxidant that protects cell membranes.

   • Dosage: Oral dose according to weight and fat-absorption status.

   • Function: To protect membranes, including mitochondrial membranes, from oxidative damage.

   • Mechanism: Interrupts lipid peroxidation chains in membranes, stabilizing them.

8. Folinic acid (active folate)
   Sometimes added when folate metabolism or brain folate levels may be low.

   • Dosage: Oral dose once or twice daily, as chosen by the specialist.

   • Function: To support DNA repair, blood cell production, and some neurotransmitter pathways.

   • Mechanism: Provides reduced folate for one-carbon transfer reactions in cells.

9. Biotin
   A B-vitamin needed for several carboxylase enzymes.

   • Dosage: Daily oral dose; high doses in specific metabolic disorders, lower in general mitochondrial cocktails.

   • Function: To support fat and carbohydrate metabolism.

   • Mechanism: Acts as a co-factor, helping enzymes add carbon dioxide to substrates in key metabolic reactions.

10. Selenium
    A trace mineral that forms part of antioxidant enzymes like glutathione peroxidase.

    • Dosage: Only if deficiency is suspected or confirmed; dose is small and carefully set.

    • Function: To support natural antioxidant enzyme systems.

    • Mechanism: Incorporated into selenoproteins that detoxify hydrogen peroxide and lipid peroxides.

---

Immune-Booster and Regenerative / Stem-Cell–Related Drugs

These options are mostly experimental or supportive, not specific cures for AARS2-related disease.

1. Vatiquinone (EPI-743 – experimental)
   An antioxidant drug studied in several mitochondrial disorders.

   • Dosage: Only given within clinical trials, under strict protocols.

   • Function: To reduce oxidative damage and improve energy metabolism.

   • Mechanism: Targets redox pathways in mitochondria, aiming to stabilize cellular energy balance.

2. Idebenone (experimental / off-label in some countries)
   A CoQ10 analogue used for some mitochondrial visual and cardiac conditions.

   • Dosage: Weight-based, multiple daily doses in studies.

   • Function: To support electron transport and act as an antioxidant.

   • Mechanism: Transfers electrons in the respiratory chain and scavenges free radicals.

3. Elamipretide (SS-31 – research stage)
   A mitochondria-targeted peptide being studied in mitochondrial disease.

   • Dosage: Given by injection or infusion in trials.

   • Function: To stabilize the inner mitochondrial membrane and cardiolipin.

   • Mechanism: Binds to cardiolipin in the inner membrane, aiming to improve electron transport and reduce reactive oxygen species.

4. Granulocyte colony-stimulating factor (G-CSF) in selected marrow problems
   Not directly for AARS2 cardiomyopathy, but sometimes used if there is associated low white cells from other causes.

   • Dosage: Short courses of injections.

   • Function: To boost neutrophil production.

   • Mechanism: Stimulates bone marrow to produce and release neutrophils.

5. IV immunoglobulin (IVIG) for immune support
   Already mentioned above, IVIG also has immune-modulating properties.

   • Dosage: Weight-based infusions.

   • Function: To temporarily strengthen immune defense or treat autoimmune overlap.

   • Mechanism: Provides antibodies and modulates over-active immune responses.

6. Experimental stem cell or gene therapies (future-oriented)
   Research is exploring stem cell and gene-editing approaches for mitochondrial and nuclear gene defects. None are standard treatment yet for AARS2.

   • Dosage: Study-specific.

   • Function: To repair or replace defective cells or genes.

   • Mechanism: May involve delivering normal gene copies or using cells that produce healthier mitochondria, but currently limited to research settings.

---

Surgeries and Procedures

1. Gastrostomy tube (G-tube) placement
   A small opening is surgically made into the stomach to place a feeding tube.

   • Procedure: Done under anesthesia, using a camera (endoscopic) or small cut.

   • Why done: To allow safe, reliable feeding when swallowing is unsafe or too tiring.

2. Implantable cardioverter-defibrillator (ICD) or pacemaker
   Devices placed under the skin with wires to the heart.

   • Procedure: Surgical implantation in the chest with leads into heart chambers.

   • Why done: To treat dangerous heart rhythm problems or support slow heart rates in severe cardiomyopathy.

3. Left ventricular assist device (LVAD) in advanced cases
   A mechanical pump supports a failing heart.

   • Procedure: Major heart surgery to connect a pump between heart and aorta.

   • Why done: As a bridge to transplant or rarely as longer-term support in end-stage heart failure.

4. Heart transplantation (in very selected patients)
   Replacing the damaged heart with a donor heart.

   • Procedure: Complex surgery in highly specialized centers.

   • Why done: For end-stage cardiomyopathy when other treatments fail and overall condition allows transplant.

5. Tracheostomy and long-term ventilation support
   A breathing tube is placed in the neck for long-term respiratory support.

   • Procedure: Surgical opening into the windpipe, then connection to ventilator.

   • Why done: When long-term breathing support is needed and non-invasive ventilation is not enough or not tolerated.

---

Prevention Strategies

Because this disease is genetic, prevention mainly means preventing recurrence and avoiding extra stress on mitochondria:

1. Genetic counseling and carrier testing for parents.

2. Prenatal or pre-implantation genetic diagnosis in future pregnancies when possible.

3. Avoidance of mitochondrial-toxic medicines when safer options exist.

4. Strict vaccination schedule to reduce infections.

5. Early and aggressive treatment of fever, vomiting, or breathing problems.

6. Avoiding prolonged fasting and dehydration, using sick-day plans.

7. Careful preparation for any surgery or anesthesia.

8. Maintaining good nutrition and growth with help from a dietitian.

9. Educating local doctors and emergency staff using written care plans.

10. Regular follow-up with the specialist team to catch changes early.

---

When to See a Doctor

You should contact a doctor urgently (or go to emergency) if a child with AARS2-related combined oxidative phosphorylation deficiency has:

• Trouble breathing, fast breathing, or blue lips.

• Very poor feeding, repeated vomiting, or no urine for many hours.

• Sudden swelling of legs, tummy, or face, or getting short of breath when lying flat.

• New or more frequent seizures, unusual sleepiness, or not waking as usual.

• High fever, rash, or signs of infection.

• Sudden chest pain, fainting, or palpitations.

Routine visits to the metabolic specialist and cardiologist are also important even when the child seems “stable,” because the disease can change silently.

---

Diet: What to Eat and What to Avoid

What to eat (5 points)

1. Frequent small meals with complex carbohydrates – such as rice, whole grains, and fruits, to give steady energy.

2. Adequate protein – from lean meat, fish, eggs, or legumes, to support growth and muscle repair.

3. Healthy fats – like olive oil and small amounts of nuts or seeds, if tolerated, to provide extra calories.

4. Plenty of fluids – water and oral rehydration solutions to avoid dehydration, especially during illness.

5. Vitamin-rich fruits and vegetables – to supply natural antioxidants and micronutrients.

What to avoid (5 points)

6. Long periods without eating – no long overnight fasts; consider a late-evening snack or continuous feeds if advised.

7. Very high-fat fad diets without specialist guidance – some specific mitochondrial disorders use ketogenic diets, but in severe cardiomyopathy this can be risky and must only be done in expert centers.

8. Sugary soft drinks and junk food that give empty calories without nutrients.

9. Unsupervised herbal or “energy” supplements – some may stress the liver or heart.

10. Extreme weight-loss or bodybuilding diets, which can push the body into dangerous catabolic states.

A mitochondrial-experienced dietitian should design the exact diet for each child.

---

Frequently Asked Questions (FAQs)

1. Is there a cure for AARS2-related combined oxidative phosphorylation deficiency?
No, there is currently no cure that fixes the AARS2 gene or fully restores mitochondrial function. Treatment focuses on supporting the heart and other organs, controlling seizures, improving nutrition, and preventing complications. Research into antioxidants, mitochondrial-targeted drugs, and gene-based therapies is ongoing, but these are not yet standard care.

2. Is this disease always fatal in infancy?
Many reported cases, especially with severe infantile cardiomyopathy, have had very poor outcomes. However, there are milder and later-onset forms, mainly with brain involvement. The course can vary by individual mutations and overall care. Your specialist can explain the child’s specific outlook based on current tests and experience.

3. Can siblings also be affected?
Yes. Because this is usually an autosomal recessive condition, parents are often healthy carriers. Each pregnancy can have a one-in-four chance of an affected child, but the exact risk depends on the family’s genetic results. Genetic counseling and testing are very important.

4. Does every child with this condition have seizures?
No, but seizures are common in mitochondrial diseases. Some children mainly have heart problems, others have more brain involvement, and some have both. Regular neurological follow-up and EEG tests help detect and treat seizures early.

5. Why are so many vitamins and supplements used?
The “mitochondrial cocktail” is used because many mitochondrial enzymes need vitamins and cofactors. While strong proof is limited, some children seem to improve in energy or stability. These supplements are usually low-risk when doses are reasonable and monitored.

6. Can exercise help or harm a child with this disease?
Gentle, carefully supervised activity usually helps maintain strength and flexibility. Over-exertion, however, can stress the heart and mitochondria. A physiotherapist and cardiologist can set safe exercise limits and rest periods.

7. Are vaccines safe in mitochondrial disease?
In general, vaccines are strongly recommended because infections can be very dangerous. The exact schedule should be confirmed with the specialist, but avoiding serious infections often brings more benefit than the small risks of vaccination.

8. Can ordinary cold or flu be dangerous?
Yes. Even “simple” viral illnesses can lead to dehydration, acidosis, and heart failure in children with severe mitochondrial disease. Sick-day plans, early fluids, and close monitoring are essential.

9. Is a ketogenic diet recommended for this condition?
Ketogenic diets have been used in some mitochondrial and seizure disorders, but in children with serious cardiomyopathy they can be risky. Such diets must never be started without a highly experienced metabolic team and cardiac monitoring.

10. Can we use herbal “energy boosters” from the internet?
This is not recommended. Many herbal products are untested in children with mitochondrial disease and may stress the liver or interact with medicines. Always discuss any supplement with the specialist team first.

11. Will my child need surgery or a heart transplant?
Some children may need procedures like a feeding tube, pacemaker, or in rare cases, heart transplantation. These decisions depend on heart function, overall health, and family wishes, and are made in specialized centers.

12. How often should heart function be checked?
Typically, echocardiograms and ECGs are done regularly (for example, every few months) and more often during changes in symptoms. The exact schedule is set by the cardiologist, based on how severe the cardiomyopathy is.

13. Can adults have AARS2-related disease?
Yes. AARS2-related disorders can present later in life with neurodegeneration and white-matter changes, sometimes without severe early heart disease. Adult neurologists and metabolic specialists should be involved in those cases.

14. Will future pregnancies be safe?
Doctors cannot guarantee safety, but genetic counseling, carrier testing, and options like pre-implantation genetic diagnosis can greatly clarify risks and choices. Each family’s options depend on their specific mutations and local regulations.

15. What is the most important thing families can do day-to-day?
Day-to-day, the key steps are: follow the treatment plan, give medicines and supplements as prescribed, prevent fasting and dehydration, watch for early signs of illness or heart failure, keep all follow-up visits, and seek emotional and social support. Close partnership with the specialist team gives the child the best chance for comfort, stability, and quality of life.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 24, 2025.